KRYS - Krystal Biotech - Stock Forecast

Healthcare - Sector
Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

KRYS is currently covered by 10 analysts with an average price target of $310.74. This is a potential upside of $48.94 (18.69%) from yesterday's end of day stock price of $261.8.

Krystal Biotech's activity chart (see below) currently has 131 price targets and 118 ratings on display. The stock rating distribution of KRYS is 93.94% BUY and 6.06% HOLD.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 87.86% with an average time for these price targets to be met of 267.07 days.

Highest price target for KRYS is $371, Lowest price target is $189, average price target is $291.9.

Most recent stock forecast was given by GEULAH LIVSHITS from CHARDAN CAPITAL on 18-Feb-2026. First documented stock forecast 18-Oct-2017.

Currently out of the existing stock ratings of KRYS, 31 are a BUY (93.94%), 2 are a HOLD (6.06%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Buy Since 29-Nov-2021

$323

$61.2 (23.38%)

$220

5 days ago
(18-Feb-2026)

15/16 (93.75%)

$39.71 (14.02%)

295

Buy Since 06-Jan-2026

$371

$109.2 (41.71%)

$336

5 days ago
(18-Feb-2026)

6/9 (66.67%)

$87.71 (30.96%)

218

Buy Since 05-Mar-2025

$371

$109.2 (41.71%)

$245

6 days ago
(17-Feb-2026)

1/2 (50%)

$83.16 (28.89%)

281

Buy Since 20-Nov-2023

$327

$65.2 (24.90%)

$160

21 days ago
(02-Feb-2026)

1/2 (50%)

$44.73 (15.85%)

99

Buy Since 18-Jan-2022

$318

$56.2 (21.47%)

$255

1 months 1 days ago
(22-Jan-2026)

5/6 (83.33%)

$28.87 (9.99%)

199

Show more analysts

Please expand the browser size to see the chart

What is KRYS (Krystal Biotech) average time for price targets to be met?

On average it took 267.07 days on average for the stock forecasts to be realized with a an average price target met ratio 87.86

Which analyst has the current highest performing score on KRYS (Krystal Biotech) with a proven track record?

GEULAH LIVSHITS

Which analyst has the most public recommendations on KRYS (Krystal Biotech)?

Geulah Livshits works at CHARDAN CAPITAL and has 13 price targets and 14 ratings on KRYS

Which analyst is the currently most bullish on KRYS (Krystal Biotech)?

Roger Song with highest potential upside - $109.2

Which analyst is the currently most reserved on KRYS (Krystal Biotech)?

Wangzhi Li with lowest potential downside - -$211.8

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?